Be Biopharma IPO

be.bio

Be Biopharma is a medical research organization specializing in the use of B cells as medicine.

Founded2020
Total Funding to Date$182.1MM
Register for Details

For more details on financing and valuation for Be Biopharma, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Be Biopharma Ticker Symbol

Be Biopharma does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Be Biopharma Stock Price

The stock price for Be Biopharma will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Major Investors for Be Biopharma

Atlas Venture
Ra Capital Management
Longwood Fund
Alta Partners
Takeda Ventures
Arch Venture Partners
Bristol Myers Squibb

Be Biopharma Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
4/14/2022 Series B $280.11MM $XXX.XX $XXX.XX
10/22/2020 Series A $91.57MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like Be Biopharma in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$885.01MM
Sector